Legend Biotech Corp. ADR (LEGN) Social Stream



Legend Biotech Corp. ADR (LEGN): $48.51

-1.02 (-2.06%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LEGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 404

in industry

Legend Biotech Corp (LEGN) Price Targets From Analysts

Use the tables below to see what analysts covering Legend Biotech Corp think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 4 $56 $50 $53 $37.02 43.17%
2021-11-19 4 $61 $51 $55.75 $37.02 50.59%
2021-11-26 4 $71 $51 $59.5 $37.02 60.72%
2022-01-06 5 $71 $51 $60.8 $37.02 64.24%
2022-02-16 5 $71 $51 $60.8 $37.02 64.24%
2022-03-01 5 $72 $51 $62 $37.02 67.48%
2022-03-07 5 $73 $55 $63.2 $37.02 70.72%
2022-03-25 6 $73 $53 $61.5 $37.02 66.13%

The Trend in the Analyst Price Target


LEGN's average price target has moved up $10.83 over the prior 21 months.

LEGN reports an average of 42.22% for its upside potential over the past 141 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-04 4 56 50 53.0 48.75 8.72%
2022-02-06 5 71 51 60.8 41.47 46.61%
2022-02-16 5 71 51 60.8 41.60 46.15%
2022-03-20 6 73 53 61.5 38.53 59.62%
2022-03-25 6 73 53 61.5 36.88 66.76%

LEGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.08 5 1 0 0 0 6

The Trend in the Broker Recommendations


LEGN's average broker recommendation rating improved by 0.03 over the prior 59 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LEGN as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Legend Biotech Corp's number of analysts covering the stock is greater than 233.57% of them.
  • In the context of Pharmaceutical Products stocks, Legend Biotech Corp's variance in analysts' estimates is lower than -108.47% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Legend Biotech Corp's upside potential (average analyst target price relative to current price) is greater than 226.01% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Legend Biotech Corp's average analyst price target is higher than 673.27% of them.

Stocks similar to Legend Biotech Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LCI, LBPS, and KRTX.

Is LEGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.552 seconds.